Cardamine komarovii (NAKAI) is a plant that is widely distributed throughout Korea. In Korea, the aerial parts of C. komarovii are considered edible. 1) This indigenous herb is used in Chinese medicine as a treatment of hemostasis, depressed blood pressure, and sedation.
2) Phytochemical studies of this plant have not yet been reported in the literature. Thus, we investigated the aerial part of C. komarovii as a part of our continuous study of the family of Cruciferae. Column chromatography based purification of CHCl 3 and n-BuOHsoluble fractions of the MeOH extract of this plant led to the isolation of three megastigmane glucopyranosides (1-3), together with eight known megastigmane compounds (4) (5) (6) (7) (8) (9) (10) (11) . The structures of the known compounds were determined to be (6R,9S)-3-oxo-a-ionol-9-O-b-D-glucopyranoside (4), 3) (6S,9S)-roseoside (5), 4) sammangaoside A (6), 5) corchoionoside A (7), 6) icariside B 2 (8), 7) (3S,5R,6R,7E,9S)-megastigman-7-ene-3,5,6,9-tetrol-3-O-b-D-glucopyranoside (9), 8) staphylionoside E (10), 9) and annuionene D (11) 10) by comparing their spectroscopic data with data in the literature (Fig 1) .
Results and Discussion
Komaroveside A (1), was obtained as a colorless gum. The molecular formula of 1 was deduced to be C 19 11) The differences were the chemical shifts in The downfield shift at C-3 implied that 1 was glycosylated at C-3.
11 12) The coupling constant (Jϭ7.6 Hz) of the anomeric proton of D-glucose indicated it to be the b-form.
12) The glycosidic site was established by an heteronuclear multiple bond correlation (HMBC) experiment, in which long-range correlation was observed between the H-3 (d H 4.01, dt, Jϭ12.3, 3.5 Hz) and the C-3 (d C 74.3) (Fig. 2 ). The glycosylated proton of H-3 at d H 4.01 (dt, Jϭ 12.3, 3.5 Hz) showed couplings in the 1 H-1 H correlation spectroscopy experiment (COSY) spectrum with H-2a, H-2b and H-4. In the HMBC experiment, long-range correlations were observed between the following protons and carbons (H-2, H-11, H-12 and C-1; H-2, H-4, H-1Ј and C-3; H-4, H-13 and C-5; H-4, H-7, H-11, H-12 and C-6; H-7, H-8, H-10 and C-9). Thus, the structure of 1 was supposed to be 3,4-dihydroxy-5,7-megastigmadien-9-one-3-O-b -D-glucoside. The relative stereochemistry of the aglycone moiety in 1 was characterized by a nuclear Overhauser enhancement spectroscopy (NOESY) experiment, which showed NOE correlations between the following proton pairs (H-2a and H-3; H2b and H-12; H-3 and H-4; H-7 and H-12) as shown in , it is suggested that two hydroxyl groups at C-3 and C-4 are in the cis configuration. 13, 14) Enzymatic hydrolysis of 1 with b-glucosidase (emulsin) yielded 3,4-dihydroxy-5,7-megastigmadien-9-one (1a, C 13 configuration at C-3 in 1a was determined by a modified version of Mosher's method. 16) Based on further comparison of the NMR data with those in the literature, the absolute configuration at C-3 in 1 was determined to be the S-form. 11, 15) Thus, the structure of 1 was determined to be (3S,4R,5Z,7E)-3,4-dihydroxy-5,7-megastigmadien-9-one-3-O-b -D-glucopyranoside, and was named komaroveside A.
Komaroveside B (2), was obtained as a colorless gum. The molecular formula of 2 was deduced to be C 19 H 30 O 9 by positive mode high resolution electrospray ionization mass spectrometry (HR-ESI-MS) data at m/z 425.1781 [MϩNa] ϩ (Calcd for C 19 H 30 O 9 Na: 425.1788). The IR spectrum of 2 showed absorption bands at 3383 and 1658 cm Ϫ1 ascribable to a hydroxyl and an unsaturated carbon, respectively. The NMR spectra of 2 were very similar to those of compound 1. In the 13 C-NMR spectrum of 2, two olefinic carbon signals observed at d C 139.9 and 131.0 in 1 were shifted upfield to d C 70.1 and 68.7 in 2, which implied that 2 has an epoxide ring instead of the double bond in 1. These observations suggested the structure of 2 to be 5,6-epoxy-3,4-dihydroxy-7-megastigmen-9-one-3-O-b-D-glucoside. The relative stereochemistry of the aglycone in 2 was characterized by a NOESY experiment, which showed NOE correlations between the following proton pairs (H-3 and H-4, 11; H-4 and H-13; H-7 and H-11, 13) as shown in Fig. 2 Hz) , it is suggested that two hydroxyl groups at C-3 and C-4 are in the cis configuration. 13, 14) Enzymatic hydrolysis of 2 with b-glucosidase (emulsin) yielded 5,6-epoxy-3,4-dihydroxy-7-megastigmen-9-one (2a, C 13 O)}. The absolute configuration at C-3 of 2a was determined to be the S-form. 11, 15) by a modified version of Mosher's method. 16) Thus, the structure of 2 was determined to be (3S,4S,5S,6R,7E)-5,6-epoxy-3,4-dihydroxy-7-megastigmen-9-one-3-O-b -D-glucopyranoside, and was named komaroveside B.
Komaroveside C (3), was obtained as a colorless gum. molecular formula of 2 was deduced to be C 19 H 34 O 10 by positive mode high resolution electrospray ionization mass spectrometry (HR-ESI-MS) data at m/z 427.1936 [MϩNa] ϩ (Calcd for C 19 H 32 O 9 Na: 427.1944. The IR spectrum of 3 showed an absorption band at 3382 cm Ϫ1 ascribable to a hydroxyl function. The NMR spectra of 3 were very similar to those of compound 2. In the NMR spectra of 3, the signals at d 35 (H-2a, dd, Jϭ12.8, 3 .5 Hz), it is suggested that two hydroxyl groups at C-3 and C-4 are in the cis configuration. 13, 14) Enzymatic hydrolysis of 3 with b-glucosidase (emulsin) yielded 5,6-epoxy-3,4,9-trihydroxy-7-megastigmen (3a, C 13 C-NMR and MS spectra were very similar to those of 5,6-epoxy-3,4,9-trihydroxy-7-megastigmen, which was isolated from Staphylea bumalda, 9) and D-glucose {[a] D 25 ϩ51°(cϭ0.05, H 2 O)}. Determination of the absolute configuration at C-3 and C-9 of 3 was done using Mosher's method. 16 ) Compound 3a, which was obtained by enzymatic hydrolysis of 3, was treated with (S)-(ϩ), and (R)-(Ϫ)-a-methoxy-a-trifluoromethylphenyl acetic acid chloride (MTPA-Cl) to give (R)-and (S)-MTPA esters (3b, c, respectively). Consequently, the absolute configurations at C-3 and C-9 in 3 were the S-form. Thus, the structure of 3 was determined to be (3S,4S,5S,6R,7E,9S)-5,6-epoxy-3,4,9-trihydroxy-7-megastigmen-3-O-b-D-glucopyranoside, and was named komaroveside C.
The cytotoxic activities of the isolated compounds (1-11) were evaluated by determining their inhibitory effects on human tumor cell lines (A549, SK-OV-3, SK-MEL-2, and HCT15) in vitro using the sulforhodamine B (SRB) assay. 17) All the compounds showed little cytotoxicity against any tested cell line (IC 50 Ͼ100 mM).
Experimental
General Experimental Procedures Optical rotations were measured on a Jasco P-1020 polarimeter in MeOH. IR spectra were recorded on a Bruker IFS-66/S FT-IR spectrometer. UV spectra were recorded with a Shimadzu UV-1601 UV-Visible spectrophotometer. ESI and HR-ESI mass spectra were obtained on a IT-TOF (Shimadzu, Japan) mass spectrometer. NMR spectra, including NOESY, COSY, heteronuclear multiple quantum coherence (HMQC) and HMBC experiments, were recorded on a Varian UNITY INOVA 500 NMR spectrometer operating at 500 MHz ( 1 H) and 125 MHz ( Extraction and Isolation The half dried aerial parts of C. komarovii (NAKAI) (1.7 kg) were extracted with 80% MeOH three times at room temperature. The resultant MeOH extracts (120 g) were suspended in distilled water (800 mlϫ3) and then successively partitioned with n-hexane, CHCl 3 , EtOAc and n-BuOH, yielding residues weighing 12 g, 13 g, 3 g and 26 g, respectively. The CHCl 3 soluble fraction (13 g) was chromatographed on a silica gel column, eluting with a gradient solvent system of CHCl 3 /MeOH (40 : 1-1 : 1) as the eluant to yield seven fraction (fr. PC1-PC7). Fraction PC3 (1.0 g) was isolated by sephadex LH-20 chromatography (80% MeOH) and was purified with a silica gel preparatory HPLC with a solvent system of CHCl 3 : MeOH (25 : 1) to yield 11 (5 mg). The n-BuOH soluble fraction (26 g) was chromatographed on a diaion HP-20 column, eluting with a gradient solvent system consisting of 100% water and 100% MeOH. This yielded two subfractions. Fraction B (48 g) was isolated using a silica gel column, eluting with a solvent system of CHCl 3 /MeOH/water (10 : 4 : 0.5). According to TLC analysis, fourteen crude fractions (fr. PB1-PB14) were collected. Fr. B3 (0.2 g) purified using a Lobar ® -A RP-18 (240ϫ10 mm) column (40% MeOH), and purified further by preparative reverse-phase HPLC, using a solvent system of 45% MeOH and 25% MeCN, yielded 4 (28 mg) and 8 (14 mg). Fr. B4 (0.5 g) purified by a Lobar ® -B RP-18 (310ϫ 25 mm) column (30% MeOH), and purified further by a preparative reversephase HPLC, using a solvent system of 30% MeOH and 20% MeCN, yielded 1 (13 mg), 2 (7 mg) and 5 (19 mg). Fr. PB5 (0.3 g) purified by a Lobar ® -A RP-18 (240ϫ10 mm) column (35% MeOH), and purified further by preparative reverse-phase HPLC, using a solvent system of 15% MeCN, yielded 6 (5 mg), 7 (10 mg) and 9 (15 mg). Fr. B7 (0.3 g), which was purified by a Lobar ® -B RP-18 (310ϫ25 mm) column (30% MeOH), and purified further by preparative normal-phase HPLC, using a solvent system of CHCl 3 / MeOH (7 : 1, 3 : 1) yielded 3 (12 mg) and 10 (9 mg).
Komaroveside , H-2b), 1.99 (3H, s, H-13), 1.71 (1H, dd, Jϭ12.3, 2.3 Hz, H-2a), Doxorubicin was used as the positive control. Regarding the cytotoxicity of doxorubicin, its IC 50 values for toxicity to A549, SK-OV-3, SK-MEL-2, and HCT15 cells, respectively, were 0.0012, 0.0214, 0.0110 and 0.1322 mM.
